chr12-120978993-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PM2_Supporting

This summary comes from the ClinGen Evidence Repository: The c.225C>G variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of asparagine to glutamate at codon 75 (p.(Asp75Glu)) of NM_000545.8. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The nucleotide change c.225C>G, which causes the same amino acid change, was classified as a VUS by by the ClinGen MDEP; therefore, PS1 will not be applied. In summary, c.225C>G meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/21): PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA386953857/MONDO:0015967/017

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

HNF1A
NM_000545.8 missense

Scores

3
6
9

Clinical Significance

Uncertain significance reviewed by expert panel U:1

Conservation

PhyloP100: -0.679

Publications

2 publications found
Variant links:
Genes affected
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]
HNF1A-AS1 (HGNC:26785): (HNF1A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNF1ANM_000545.8 linkc.225C>G p.Asp75Glu missense_variant Exon 1 of 10 ENST00000257555.11 NP_000536.6
HNF1ANM_001306179.2 linkc.225C>G p.Asp75Glu missense_variant Exon 1 of 10 NP_001293108.2
HNF1ANM_001406915.1 linkc.225C>G p.Asp75Glu missense_variant Exon 1 of 9 NP_001393844.1
HNF1AXM_024449168.2 linkc.225C>G p.Asp75Glu missense_variant Exon 1 of 9 XP_024304936.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNF1AENST00000257555.11 linkc.225C>G p.Asp75Glu missense_variant Exon 1 of 10 1 NM_000545.8 ENSP00000257555.5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.87e-7
AC:
1
AN:
1456572
Hom.:
0
Cov.:
35
AF XY:
0.00000138
AC XY:
1
AN XY:
724152
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33414
American (AMR)
AF:
0.00
AC:
0
AN:
43642
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25940
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39524
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85434
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52902
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1109754
Other (OTH)
AF:
0.00
AC:
0
AN:
60202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Monogenic diabetes Uncertain:1
Apr 08, 2022
ClinGen Monogenic Diabetes Variant Curation Expert Panel
Significance:Uncertain significance
Review Status:reviewed by expert panel
Collection Method:curation

The c.225C>G variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of asparagine to glutamate at codon 75 (p.(Asp75Glu)) of NM_000545.8. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The nucleotide change c.225C>G, which causes the same amino acid change, was classified as a VUS by by the ClinGen MDEP; therefore, PS1 will not be applied. In summary, c.225C>G meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/21): PM2_Supporting. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
14
DANN
Uncertain
0.97
DEOGEN2
Uncertain
0.48
.;T;T;D;T;.
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.87
D;D;D;D;D;D
M_CAP
Pathogenic
0.33
D
MetaRNN
Benign
0.19
T;T;T;T;T;T
MetaSVM
Uncertain
0.19
D
PhyloP100
-0.68
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.25
N;.;.;N;N;N
REVEL
Uncertain
0.56
Sift
Benign
0.40
T;.;.;T;T;T
Sift4G
Benign
0.28
T;T;T;T;T;T
Polyphen
0.74
.;.;.;.;.;P
Vest4
0.17
MutPred
0.68
Gain of relative solvent accessibility (P = 0.2629);Gain of relative solvent accessibility (P = 0.2629);Gain of relative solvent accessibility (P = 0.2629);Gain of relative solvent accessibility (P = 0.2629);Gain of relative solvent accessibility (P = 0.2629);Gain of relative solvent accessibility (P = 0.2629);
MVP
0.97
MPC
0.30
ClinPred
0.39
T
GERP RS
-0.11
PromoterAI
-0.023
Neutral
gMVP
0.67
Mutation Taster
=5/95
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202180554; hg19: chr12-121416796; API